Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	159.42	51.48	19.84
Graham Fair Price	175.95	92604.02	33557.71
PEG	-98.32	-0.01	0.77
Price/Book	-0.82	0.84	0.85
Price/Cash Flow	-64.67	13.27	37.55
Prices/Earnings	-86.49	11.20	-82.90
Price/Sales	13.13	1.53	1.36
Price/FCF	-64.67	13.27	37.55
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-14.60	0.06	0.07
Operating Margin	-48.40	0.03	0.06
ROA	641.53	< 0.005	< 0.005
ROE	< 0.005	0.02	634.10
ROIC	0.09	< 0.005	-89.48
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.14	-0.01	-845.35
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	4.04	-0.54	-86.66
EPS QOQ	-1.07	8.65	704.56
FCF QOQ	-0.68	1.86	172.76
Revenue QOQ	0.23	-0.11	-53.96
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	31.47	38.52	22.38
Days Sales Outstanding (DSO)	125.87	137.66	9.37
Inventory Turnover	2.86	2.34	-18.29
Debt/Capitalization	0.29	0.25	-11.84
Quick Ratio	0.76	0.74	-1.65
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	140051.51	142641.80	1.85
Cash	65248.30	65803.26	0.85
Capex	-3522.77	-2767.04	21.45
Free Cash Flow	3155.61	9022.88	185.93
Revenue	87356.75	77998.00	-10.71
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.01	1.02	0.48
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.11	-1.36	-35.53
Naive Interpretation	Member

06 - Financial Health · Bad

Rating